Potentially Pathogenic Calcium Oxalate Dihydrate and Titanium Dioxide Crystals in the Alzheimer’s Disease Entorhinal Cortex
Abstract
Knowing that Alzheimer’s disease (AD) nucleates in the entorhinal cortex (EC), samples of 12 EC specimens were probed for crystals by a protocol detecting fewer than 1/5000th of those present. Of the 61 crystals found, 31 were expected and 30 were novel. Twenty-one crystals of iron oxides and 10 atherosclerosis-associated calcium pyrophosphate dihydrate crystals were expected and found. The 30 unexpected crystals were NLRP3-inflammasome activating calcium oxalate dihydrate (12) and titanium dioxide (18). Their unusual distribution raises the possibility that some were of AD origination sites.
Alzheimer’s disease (AD) nucleates in a small volume-element of the entorhinal cortex (EC) [1, 2], spreads in the EC, expands to the hippocampus then to other parts of the cortex. AD’s hallmark aggregated amyloid-β (Aβ) peptide and hyperphosphorylated tau protein are established propagators of AD, but it is not known if they are its cause. Their presence at the EC initiation-point has not been established. The initiation-point could be microbial [3], cholesterol comprising [4, 5], or as will be discussed below, it could comprise pathogenic crystals.
Macrophage [6] and microglial NLRP3 [7–10] and NLRP1 [11, 12] inflammasomes assemble upon phagocytosis of species having certain molecular patterns. The patterns include those of aggregated Aβ42 [7, 8], of aggregated hyperphosphorylated tau [10, 13, 14], of pathogens or their fragments [13, 15], and of biogenic and exogenous crystals. The family of inflammasome-activating biogenic crystals includes sodium urate [16–18], cholesterol [19, 20], calcium oxalate dihydrate (COD) [17, 18], calcium pyrophosphate dihydrate (CPPD) [16, 17], and cystine [17]. The family of exogenous crystals includes quartz [21–23], asbestos [21], titanium dioxide (TiO2) [18, 23], and sintered indium tin oxide [24].
Activation of the NLRP3 inflammasome initiates release of IL-1β and other inflammatory cytokines and induces, through a multistep process, pyroptosis, the death of proximal cells. Upon death of proximal neurons more aggregating Aβ and hyperphosphorylated tau are released and more neurons and synapses perish [10].
The commonality of microbial patterns [13, 15], cholesterol [19, 20], Aβ aggregates [7, 25], and hyperphosphorylated tau aggregates [10] is that all activate the NLRP3 inflammasome. In light of this commonality, we ask here if there are NLRP3 inflammasome-activating crystals in postmortem EC specimens of AD donors [17, 18] that could also be among the point-initiators of AD.
Duplicate 200 mg samples of 12 formalin-fixed entorhinal cortex specimens, provided by the NIH Harvard Neurobiobank, were probed. Six of the specimens were of Braak and Braak stages I or II [1] and 6 were of stage V [1]. The samples were homogenized with 1 mL of an aqueous solution containing 40 mg of Proteinase K from Tritirachium album (Sigma P2308). Instead of using the usual crystalline zirconia beads that would have introduced zirconia crystals, the samples were homogenized using 3 mm-diameter non-crystalline Pyrex glass beads. After overnight proteolysis at ambient temperature, the fluid was centrifuged at 13,000 G for 1 h, the supernatant was discarded, and the centrifugate was re-suspended in 0.5 mL de-ionized water and re-centrifuged for 1 h. To strip the water-soluble salts that would have crystallized upon evaporation of the water, the centrifugate was re-suspended in 0.5 mL water, centrifuged at 13,000 G for 10 min, and the supernatant liquid was discarded. The washing-centrifugation cycle was repeated four times, then the final centrifugate was suspended in 0.5 mL water. Five μL of the suspension was withdrawn from the bottom of the vial and applied to a 3 mm diameter, 314 squares, 200 mesh carbon type-B transmission electron microscopy grid support (Ted Pella, Redding CA). The crystals were observed on duplicate grids from duplicate EC samples, i.e., in 2×5 = 10μL, applied to each grid-pair. The grid-pairs were TEM scanned for presence of crystals, then 5 squares of the grid-pair were probed. Because 10μL of the 0.5 mL processed volume was applied to the 2×314 = 628 squares, and because only 5 squares were probed, fewer than 0.015% of the present crystals were detected; furthermore, because the 2×200 mg samples comprised less than 1/5th of the entorhinal cortices, each detected crystal signaled the presence of more than 25,000.
Each detected crystal was TEM-imaged; after confirmation of its crystallinity by its electron diffraction pattern, the crystal’s approximate (±5 atom %) elemental composition was determined by energy-dispersive X-ray spectroscopy. Oxygen-assays of those crystals that rapidly lost their water of hydration in the vacuum of the TEM chamber were less accurate; and with the TEM grids being of carbon, and with tissue-residue adhering to the crystals, their carbon was not assayed. If cholesterol crystals were present, these would not have been observed because their 1.05 g cm–3 density prevents their separation by centrifugation.
Tables 1 and 2 list the 61 detected crystals: Table 1 listing those that we expected and Table 2 listing those that surprised us. We expected the iron oxide crystals, including the 16 ferrihydrite crystals dehydrating in the TEM’s vacuum chamber to crystalline goethite (Supplementary Figure 1, top left), and the 5 magnetite crystals, from earlier studies of crystals in the AD cortex [26–28]. The crystalline oxides of iron have not been reported to activate the NLRP3 inflammasome. The 10 CPPD crystals, dehydrating in the TEM’s vacuum chamber to calcium pyrophosphate, did not surprise us, because the NIH Harvard Neurobiobank histopathology reports of their donor brains included atherosclerotic plaques [29]. We note, nevertheless, that CPPD is inflammasome-activating [16].
Table 1
Anticipated and found crystals in the AD entorhinal cortex
| EC Specimen | AD Stage | Ferrihydrite/Goethite | Magnetite | CPPD |
| 8191 | I | 0 | 2 | 0 |
| 9232 | I | 1 | 0 | 0 |
| 9078 | I | 1 | 0 | 3 |
| 6675 | I | 4 | 1 | 3 |
| 1202 | II | 0 | 1 | 0 |
| 17142 | II | 0 | 0 | 3 |
| 2818 | V | 1 | 0 | 0 |
| 0275 | V | 1 | 0 | 0 |
| 13857 | V | 2 | 1 | 1 |
| 9540 | V | 1 | 0 | 0 |
| 8818 | V | 0 | 0 | 0 |
| 3273 | V | 5 | 0 | 0 |
| Total | 16 | 5 | 10 |
Table 2
Novel inflammasome-activating crystals in the AD entorhinal cortex
| Donor | Age | AD Stage | COD | TiO2 |
| 8191 | 65 | I | 0 | 0 |
| 9232 | 58 | I | 1 | 0 |
| 9078 | 60 | I | 1 | 0 |
| 6675 | 66 | I | 1 | 3 |
| 1202 | 74 | II | 1 | 0 |
| 17142 | 83 | II | 0 | 1 |
| 2818 | 73 | V | 0 | 0 |
| 275 | 74 | V | 2 | 1 |
| 13857 | 62 | V | 0 | 3 |
| 9540 | 86 | V | 0 | 3 |
| 8818 | 85 | V | 6 | 0 |
| 3273 | 85 | V | 0 | 7 |
| Total | 12 | 18 |
The 30 unanticipated crystals are listed in Table 2. Twelve were COD crystals of 0.8×0.5μm average imaged area (Supplementary Figure 1, top right) and 18 were TiO2 crystals of 0.3×0.2μm averaged imaged area (Supplementary Figure 1, bottom). The 30 crystals were unevenly distributed between the early and the advanced stage AD specimens, with 22 in the 6 specimens of stage V, and 8 in the 6 specimens of stages I or II. Specimen 8818 of stage V contained half of all the 12 COD crystals and specimen 3273, also of stage V, contained 7 of the 18 TiO2 crystals.
The COD crystals lost their water of hydration, fracturing, but remaining crystalline in the vacuum of the TEM chamber, then decomposing under the electron beam to crytalline calcium carbonate and finally to crystalline calcium oxide, CaC2O4.2H2O ⟶ CaC2O4 + 2H2O↑ ⟶ CaCO3 + CO↑ ⟶ CaO+CO2 ↑. Correspondingly, the Ca/O atom ratio increased from 1 : 6 to 1 : 4, then from 1 : 4 to 1 : 3, then from 1 : 3 to 1 : 1.
Phagocytized COD crystals are residents of chronic sterile inflammations of the kidneys and of the cyst [30]. They are found also in the brain after xylitol administration [31], after ethylene glycol (antifreeze) poisoning [32], and in hyperoxaluria [33]. We also found these in the substantia nigra of Parkinson’s disease donors [34].
COD precipitates when the [Ca2 +][oxalate] product-defined solubility-limit is exceeded, i.e., when the Ca2 + concentration is high, when the oxalate concentration is high, or when both are higher than normal. Because exaggerated endothelial reticulum Ca2 + release, leading to elevation of neuronal cytosolic Ca2 + concentration, precedes in the mouse model aggregation of Aβ42 [35], the precipitation of inflammasome-activating COD crystals is not likely to be a result of AD, and can be one of its causes. In the absence of xylitol or ethylene glycol poisoning the oxalate precursors in the CNS is ascorbate [36]. The neuronal concentration of ascorbate is as high as 10 mM [37], twice that of glucose; and the concentration of ascorbate in stimulated macrophages is massive [38], making it likely that it is similarly massive in stimulated microglia. Excessive ascorbate concentration is a recognized cause of sterile inflammatory COD disease [39].
The TiO2 particles of the observed size constitute the white pigment of walls. Smaller TiO2 particles, constituting the white pigment of medications, foods, and cosmetics, were found in the pancreas of obese type 2 diabetic donors [40], their number density scaling with obesity [41].
In conclusion, our study suggests that entorhinal cortex COD and TiO2 crystals should be added to the existing list of potential AD initiators, all known to activate the NLRP3 inflammasome.
ACKNOWLEDGMENTS
The authors are grateful to the NIH Harvard NeuroBioBank for the specimens and their histopathology. A.H. thanks the Welch Foundation (Grant F-1131) for supporting this study.
Authors’ disclosures available online (https://www.j-alz.com/manuscript-disclosures/20-0535r1).
SUPPLEMENTARY MATERIAL
[1] The supplementary material is available in the electronic version of this article: https://dx.doi.org/10.3233/JAD-200535.
REFERENCES
[1] | Braak H , Braak E ((1991) ) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: , 239–259. |
[2] | Kaufman SK , Del Tredici K , Thomas TL , Braak H , Diamond MI ((2018) ) Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART. Acta Neuropathol 136: , 57–67. |
[3] | Maheshwari P , Eslick GD ((2015) ) Bacterial infection and Alzheimer’s disease: A meta-analysis. J Alzheimers Dis 43: , 957–966. |
[4] | Shobab LA , Hsiung GY , Feldman HH ((2005) ) Cholesterol in Alzheimer’s disease. Lancet Neurol 4: , 841–852. |
[5] | Toro P , Degen C , Pierer M , Gustafson D , Schröder J , Schönknecht P ((2014) ) Cholesterol in mild cognitive impairment and Alzheimer’s disease in a birth cohort over 14 years. Eur Arch Psychiatry Clin Neurosci 264: , 485–492. |
[6] | Martinon F , Burns K , Tschopp J ((2002) ) The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10: , 417–426. |
[7] | Halle A , Hornung V , Petzold GC , Stewart CR , Monks BG , Reinheckel T , Fitzgerald KA , Latz E , Moore KJ , Golenbock DT ((2008) ) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9: , 857–865. |
[8] | Heneka MT , Kummer MP , Stutz A , Delekate A , Schwartz S , Vieira-Saecker A , Griep A , Axt D , Remus A , Tzeng TC , Gelpi E , Halle A , Korte M , Latz E , Golenbock DT ((2013) ) NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 493: , 674–678. |
[9] | Terrill-Usery SE , Mohan MJ , Nichols MR ((2014) ) Amyloid-β(1-42) protofibrils stimulate a quantum of secreted IL-1β despite significant intracellular IL-1β accumulation in microglia. Biochim Biophys Acta 1842: , 2276–2285. |
[10] | Ising C , Venegas C , Zhang S , Scheiblich H , Schmidt SV , Vieira-Saecker A , Schwartz S , Albasset S , McManus RM , Tejera D , Griep A , Santarelli F , Brosseron F , Opitz S , Stunden J , Merten M , Kayed R , Golenbock DT , Blum D , Latz E , Buée L , Heneka MT ((2019) ) NLRP3 inflammasome activation drives tau pathology. Nature 575: , 669–673. |
[11] | Kaushal V , Dye R , Pakavathkumar P , Foveau B , Flores J , Hyman B , Ghetti B , Koller BH , Le Blanc AC ((2015) ) Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation. Cell Death Differ 22: , 1676–1686. |
[12] | Yap JKY , Pickard BS , Chan EWL , Gan SY ((2019) ) The role of neuronal NLRP1 inflammasome in Alzheimer’s disease: Bringing neurons into the neuroinflammation game. Mol Neurobiol 56: , 7741–7753. |
[13] | Olsen I , Singhrao SK ((2016) ) Inflammasome involvement in Alzheimer’s disease. J Alzheimers Dis 54: , 45–53. |
[14] | Ahmed ME , Iyer S , Thangavel R , Kempuraj D , Selvakumar GP , Raikwar SP , Zaheer S , Zaheer A ((2017) ) Co-localization of glia maturation factor with NLRP3 inflammasome and autophagosome markers in human Alzheimer’s disease brain. J Alzheimers Dis 60: , 1143–1160. |
[15] | Martinon F , Agostini L , Meylan E , Tschopp J ((2004) ) Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr Biol 14: , 1929–1934. |
[16] | Martinon F , Petrilli V , Mayor A , Tardivel A , Tschopp J ((2006) ) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: , 237–241. |
[17] | Mulay SR , Desai J , Kumar SV , Eberhard JN , Thomasova D , Romoli S , Grigorescu M , Kulkarni OP , Popper B , Vielhauer V , Zuchtriegel G , Reichel C , Braesen JH , Romagnani P , Bilyy R , Munoz LE , Herrmann M , Liapis H , Krautwald S , Linkermann A , Anders H-J ((2016) ) Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat Commun 7: , 10274. |
[18] | Honarpisheh M , Foresto-Neto O , Desai J , Steiger S , Gomez LA , Anders HJ , Mulay SR , Popper B , Boor P ((2017) ) Phagocytosis of environmental or metabolic crystalline particles induces cytotoxicity by triggering necroptosis across a broad range of particle size and shape. Sci Rep 7: , 15523. |
[19] | Rajamaki K , Lappalainen J , Oorni K , Valimaki E , Matikainen S , Kovanen PT , Eklund KK ((2010) ) Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: A novel link between cholesterol metabolism and inflammation. PLoS One 5: , e11765. |
[20] | Duewell P , Kono H , Rayner KJ , Sirois CM , Vladimer G , Bauernfeind FG , Abela GS , Franchi L , Nunez G , Schnurr M , Espevik T , Lien E , Fitzgerald KA , Rock KL , Moore KJ , Wright SD , Hornung V , Latz E ((2010) ) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: , 1357–1361. |
[21] | Dostert C , Petrilli V , Van Bruggen R , Steele C , Mossman BT , Tschopp J ((2008) ) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320: , 674–677. |
[22] | Cassel SL , Eisenbarth SC , Iyer SS , Sadler JJ , Colegio OR , Tephly LA , Carter AB , Rothman PB , Flavell RA , Sutterwala FS ((2008) ) The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A 105: , 9035–9040. |
[23] | Winter M , Beer HD , Hornung V , Kramer U , Schins RP , Forster I , Ruiz PA , Moron B , Becker HM , Lang S , Atrott K , Spalinger MR , Scharl M , Wojtal KA , Fischbeck-Terhalle A , Frey-Wagner I , Hausmann M , Kraemer T , Rogler G ((2011) ) Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells. Nanotoxicology 5: , 326–340. |
[24] | Badding MA , Schwegler-Berry D , Park JH , Fix NR , Cummings KJ , Leonard SS ((2015) ) Sintered indium-tin oxide particles induce pro-inflammatory responses in vitro, in part through inflammasome activation. PLoS One 10: , e0124368. |
[25] | Salminen A , Ojala J , Suuronen T , Kaarniranta K , Kauppinen A ((2008) ) Amyloid-β oligomers set fire to inflammasomes and induce Alzheimer’s pathology. J Cell Mol Med 12: , 2255–2262. |
[26] | Dobson J ((2001) ) Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett 496: , 1–5. |
[27] | Collingwood JF , Chong RK , Kasama T , Cervera-Gontard L , Dunin-Borkowski RE , Perry G , Posfai M , Siedlak SL , Simpson ET , Smith MA , Dobson J ((2008) ) Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer’s plaque core material. J Alzheimers Dis 14: , 235–245. |
[28] | Pankhurst Q , Hautot D , Khan N , Dobson J ((2008) ) Increased levels of magnetic iron compounds in Alzheimer’s disease. J Alzheimers Dis 13: , 49–52. |
[29] | Panh L , Lairez O , Galinier M , Carrie D , Ruidavets J-B , Ferrieres J ((2017) ) Coronary artery calcification: From crystal to plaque rupture. Arch Cardiovasc Dis 110: , 550–561. |
[30] | Kusmartsev S , Dominguez-Gutierrez PR , Canales BK , Bird VG , Vieweg J , Khan SR ((2016) ) Calcium oxalate stone fragment and crystal phagocytosis by human macrophages. J Urol 195: , 1143–1151. |
[31] | Evans GW , Phillips G , Mukherjee TM , Snow MR , Lawrence JR , Thomas DW ((1973) ) Identification of crystals deposited in brain and kidney after xylitol administration by biochemical, histochemical, and electron diffraction methods. J Clin Pathol 26: , 32–36. |
[32] | Gaultier M , Conso F , Rudler M , Leclerc JP , Mellerio F ((1976) ) [Acute ethylene glycol poisoning]. Eur J Toxicol Environ Hyg 9: , 373–379. |
[33] | Haqqani MT ((1977) ) Crystals in brain and meninges in primary hyperoxaluria and oxalosis. J Clin Pathol 30: , 16–18. |
[34] | Heller A , Coffman SS ((2019) ) Crystals in the substantia nigra. ACS Chem Neurosci 10: , 3415–3418. |
[35] | Foskett JK ((2010) ) Inositol trisphosphate receptor Ca2+release channels in neurological diseases. Pflügers Arch 460: , 481–494. |
[36] | Linster CL , Van Schaftingen E ((2007) ) Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J 274: , 1–22. |
[37] | Rice ME , Russo-Menna I ((1997) ) Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience 82: , 1213–1223. |
[38] | May JM , Huang J , Qu ZC ((2005) ) Macrophage uptake and recycling of ascorbic acid: Response to activation by lipopolysaccharide. Free Radic Biol Med 39: , 1449–1459. |
[39] | Yu JT , Chang RC , Tan L , Bojarski L , Herms J , Kuznicki J , Mattson MP , Chan SL , Mattson MP , Guo Q , Furukawa K , Pedersen WA , Guo Q , Robinson N , Mattson MP ((2009) ) Calcium dysregulation in Alzheimer’s disease: From mechanisms to therapeutic opportunities. Prog Neurobiol 89: , 240–255. |
[40] | Heller A , Jarvis K , Coffman SS ((2018) ) Association of type 2 diabetes with submicron titanium dioxide crystals in the pancreas. Chem Res Toxicol 31: , 506–509. |
[41] | Heller A , Coffman SS , Friedman KA ((2019) ) Obesity-dependent accumulation of titanium in the pancreas of type 2 diabetic donors. Chem Res Toxicol 32: , 1351–1356. |
